FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/075873 [Registered on: 25/10/2024] Trial Registered Prospectively
Last Modified On: 24/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To study the add on effect of Ayurvedic Decoction with Metformin-SR in the treatment of diabetes 
Scientific Title of Study   Clinical study of add on effect of Kutaj-asanadi kwath along with Metformin-SR in the management of Prameha(NIDDM) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shubhangi Raviraj Chate 
Designation  PG Scholar Kayachikitsa 
Affiliation  Tilak Ayurved Mahavidyalaya 
Address  Department of Kayachikitsa, Tilak Ayurved Mahavidyalaya, Rasta Peth, Pune

Pune
MAHARASHTRA
411011
India 
Phone  9145722234  
Fax    
Email  shubhangichate0304@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sadanand V Deshpande 
Designation  HOD and Professor Kayachikitsa department 
Affiliation  Tilak Ayurved Mahavidyalaya 
Address  Department of Kayachikitsa, Tilak Ayurved Mahavidyalaya, Rasta Peth, Pune

Pune
MAHARASHTRA
411011
India 
Phone  9960071113  
Fax    
Email  drsvdeshpande61@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sadanand V Deshpande 
Designation  HOD and Professor Kayachikitsa department 
Affiliation  Tilak Ayurved Mahavidyalaya 
Address  Department of Kayachikitsa, Tilak Ayurved Mahavidyalaya, Rasta Peth, Pune


MAHARASHTRA
411011
India 
Phone  9960071113  
Fax    
Email  drsvdeshpande61@gmail.com  
 
Source of Monetary or Material Support  
Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurvedic Hospital, Rasta peth, Pune 
 
Primary Sponsor  
Name  Tilak Ayurveda Mahavidyalaya 
Address  Tilak Ayurved Mahavidyalaya, Department of Kayachikitsa, 1st floor, 583/2, Rasta peth, Pune- 411011 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shubhangi Raviraj Chate  Seth Tarachand Ramnath Ayurvedic Hospital Pune  Tilak Ayurved Mahavidyalaya, Department of Kayachikitsa, OPD no. 5, Ground floor, Rasta peth, Pune-411011
Pune
MAHARASHTRA 
9145722234

shubhangichate0304@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee, TAMV Pune  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E11||Type 2 diabetes mellitus. Ayurveda Condition: PRAMEHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Metformin SRMetformin is in a class of drugs called Biguanides which controls blood sugar levels. Dose- 500mg orally twice a day for 3 months
2Intervention ArmDrugClassical(1) Medicine Name: Kutaj-asanadi kwath, Reference: Yogratnakar Prameha Chikitsa, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -Madhu), Additional Information: to be given along with Metformin-SR 500mg for 3months
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patients having signs and symptoms of prameha.
Blood sugar level between -
Fasting:126-160mg/dl
Post Prandial:160-250mg/dl
HbA1C:6.5-9% 
 
ExclusionCriteria 
Details  Type 1 Diabetes mellitus
Patient on insulin or steroid treatment
Pregnant women and lactating mother
Patient with any other systemic disorder
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in blood sugar level
Change in HbA1C value for glycemic control in diabetic patients  
with gap of every 15days for 3months 
 
Secondary Outcome  
Outcome  TimePoints 
Recurrence of burning sensation at Hand, foot & sole
Recurrence of thirst 
90days 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   11/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Diabetes mellitus is a clinical syndrome characterized by hyperglycemia caused by an absolute or relative deficiency of insulin and insulin resistance, lack of insulin, whether absolute or relative and affects the metabolism of carbohydrates. Type 2 diabetes mellitus has become an global epidemic. Modern medicine despite of offering variety of effect to treatment options can have several adverse effects. Ayurvedic management of diabetes aim not only to achieve strict glycemic control but also to treat main route cause of disease. Many drug and formula have described for internal and external use in ayurvedic samhitas one of which is Kutaj-asanadi kwath. This synopsis is an attempt to study the add on effect of Kutaj-asanadi kwath in prameha and improve the personal and social lack of patient which contain Kutaj, asanad, triphala which helps to reduce symptoms of prameha. The prevalance of DM is 11.5%
Subject to parameters for measurment
1. Prabhuta mutrata
2. Pipasa
3. Kara-pada-tala daha
Overall assessment of the result will made by considering the collective effect on all the parameters and scoring criteria.
 
Close